A detailed history of Ogorek Anthony Joseph transactions in Abb Vie Inc. stock. As of the latest transaction made, Ogorek Anthony Joseph holds 1,223 shares of ABBV stock, worth $223,906. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,223
Previous 1,161 5.34%
Holding current value
$223,906
Previous $199,000 21.11%
% of portfolio
0.08%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$163.84 - $199.33 $10,158 - $12,358
62 Added 5.34%
1,223 $241,000
Q1 2024

May 03, 2024

SELL
$159.82 - $182.1 $18,379 - $20,941
-115 Reduced 9.01%
1,161 $211,000
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $13,760 - $15,497
100 Added 8.5%
1,276 $197,000
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $2,003 - $2,319
15 Added 1.29%
1,176 $175,000
Q3 2017

Oct 25, 2017

BUY
$69.85 - $89.22 $81,095 - $103,584
1,161
1,161 $103,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ogorek Anthony Joseph Portfolio

Follow Ogorek Anthony Joseph and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ogorek Anthony Joseph , based on Form 13F filings with the SEC.

News

Stay updated on Ogorek Anthony Joseph with notifications on news.